In a retrospective review of 251 patients undergoing prostate biopsy for PSA > 4.0 ng/mL, there was a statistically significant difference in the natural log of CRP between BPH, ≤T2, and ≥T3 cancers (50). The gene discussed is CRP; the disease is cancer.